Cargando...

Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications

Proton pump inhibitors (PPIs) remain the superior choice worldwide in antisecretory therapy in the evidence-based treatment of upper gastrointestinal disorders including gastroesophageal reflux disease, erosive esophagitis, dyspepsia and peptic ulcer disease. PPI overutilization in ambulatory care s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Heidelbaugh, Joel J.
Formato: Artigo
Lenguaje:Inglês
Publicado: SAGE Publications 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4110863/
https://ncbi.nlm.nih.gov/pubmed/25083257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098613482484
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!